Docoh
Loading...

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
a broad range of factors relating to the qualifications and background of nominees. Although we have no formal policy regarding Board diversity, we … , independence, background, age, expertise, diversity of experience, length of service and other commitments. Additionally, while the nominating and governance
10-K/A
2020 FY
PCSA Processa Pharmaceuticals Inc
7 Apr 21
Annual report (amended)
4:23pm
of Directors may consider a broad range of factors relating to the qualifications and background of nominees, which may include diversity, which … is not only limited to race, gender or national origin. We have no formal policy regarding Board diversity. Our Board of Directors’ priority in selecting
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
and background of nominees, which may include diversity, which is not only limited to race, gender or national origin. We have no formal policy regarding … Board diversity. Our Board of Directors’ priority in selecting Board members is identification of persons who will further the interests of our
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
of Directors may consider a broad range of factors relating to the qualifications and background of nominees, which may include diversity, which … is not only limited to race, gender or national origin. We have no formal policy regarding Board diversity. Our Board of Directors’ priority in selecting Board
S-1/A
PCSA Processa Pharmaceuticals Inc
16 Sep 20
IPO registration (amended)
8:00pm
of Directors may consider a broad range of factors relating to the qualifications and background of nominees, which may include diversity, which … is not only limited to race, gender or national origin. We have no formal policy regarding Board diversity. Our Board of Directors’ priority in selecting Board
S-1/A
PCSA Processa Pharmaceuticals Inc
17 Jul 20
IPO registration (amended)
5:25pm
of nominees, which may include diversity, which is not only limited to race, gender or national origin. We have no formal policy regarding board diversity
10-K
2019 FY
PCSA Processa Pharmaceuticals Inc
5 Mar 20
Annual report
7:00pm
and background of nominees, which may include diversity, which is not only limited to race, gender or national origin. We have no formal policy … regarding board diversity. Our board of directors’ priority in selecting board members is identification of persons who will further the interests of our
S-1
PCSA Processa Pharmaceuticals Inc
13 Dec 19
IPO registration
5:32pm
. Our board of directors may consider a broad range of factors relating to the qualifications and background of nominees, which may include diversity … , which is not only limited to race, gender or national origin. We have no formal policy regarding board diversity. Our board of directors’ priority
DEF 14A
PCSA Processa Pharmaceuticals Inc
26 Apr 19
Definitive proxy
5:02pm
factors in evaluating such candidates, including issues of character, judgment, independence, background, age, expertise, diversity of experience, length … of service and other commitments. Additionally, while the Board does not have a formal policy with respect to diversity, it seeks to have a Board
  • 1